Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00460603

Public ClinicalTrials.gov record NCT00460603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 25, 2026, 4:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Combinations With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer Preceded By A Phase 1 Portion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the safety and efficacy of AG-013736 in combination with other standard of care medication in patients with first line metastatic colorectal cancer.

Study identification

NCT ID
NCT00460603
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
187 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Mar 31, 2012
Completion
Oct 31, 2012
Last update posted
Dec 5, 2013

2006 – 2012

United States locations

U.S. sites
106
U.S. states
23
U.S. cities
86
Facility City State ZIP Site status
Pfizer Investigational Site Daphne Alabama 36526 —
Pfizer Investigational Site Huntsville Alabama 35801 —
Pfizer Investigational Site Huntsville Alabama 35805 —
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Antioch California 94531 —
Pfizer Investigational Site Colton California 92324 —
Pfizer Investigational Site Corona California 92879 —
Pfizer Investigational Site Gilroy California 95020 —
Pfizer Investigational Site Glendora California 91741 —
Pfizer Investigational Site La Jolla California 92037 —
Pfizer Investigational Site La Jolla California 92093 —
Pfizer Investigational Site Pasadena California 91105 —
Pfizer Investigational Site Pleasant Hill California 94523 —
Pfizer Investigational Site Pomona California 91767 —
Pfizer Investigational Site Rancho Cucamonga California 91730 —
Pfizer Investigational Site Rancho Mirage California 92270 —
Pfizer Investigational Site Redlands California 92374 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site San Diego California 92121 —
Pfizer Investigational Site San Leandro California 94578 —
Pfizer Investigational Site West Covina California 91790 —
Pfizer Investigational Site Auroa Colorado 80012 —
Pfizer Investigational Site Boulder Colorado 80303 —
Pfizer Investigational Site Colorado Springs Colorado 80909 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Lakewood Colorado 80228 —
Pfizer Investigational Site Littleton Colorado 80120-4413 —
Pfizer Investigational Site Lone Tree Colorado 80124 —
Pfizer Investigational Site Longmont Colorado 80501 —
Pfizer Investigational Site Parker Colorado 80138 —
Pfizer Investigational Site Thornton Colorado 80260 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Stuart Florida 34994 —
Pfizer Investigational Site Atlanta Georgia 30318 —
Pfizer Investigational Site Beech Grove Indiana 46107 —
Pfizer Investigational Site Indianapolis Indiana 46237 —
Pfizer Investigational Site Jeffersonville Indiana 47130 —
Pfizer Investigational Site Muncie Indiana 47303 —
Pfizer Investigational Site Kansas City Kansas 66112 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Louisville Kentucky 40202 —
Pfizer Investigational Site Louisville Kentucky 40207 —
Pfizer Investigational Site Louisville Kentucky 40217 —
Pfizer Investigational Site Louisville Kentucky 40241 —
Pfizer Investigational Site Shelbyville Kentucky 40065 —
Pfizer Investigational Site Baton Rouge Louisiana 70809 —
Pfizer Investigational Site Brownstone Michigan 48183 —
Pfizer Investigational Site Dearborn Michigan 48126 —
Pfizer Investigational Site Detroit Michigan 48202 —
Pfizer Investigational Site West Bloomfield Michigan 48322 —
Pfizer Investigational Site Kansas City Missouri 64111 —
Pfizer Investigational Site Kansas City Missouri 64131 —
Pfizer Investigational Site Kansas City Missouri 64154 —
Pfizer Investigational Site Lee's Summit Missouri 64064 —
Pfizer Investigational Site St Louis Missouri 63110 —
Pfizer Investigational Site Grand Island Nebraska 68803 —
Pfizer Investigational Site Las Vegas Nevada 89135 —
Pfizer Investigational Site Summit New Jersey 07902 —
Pfizer Investigational Site Albany New York 12206 —
Pfizer Investigational Site Albany New York 12208 —
Pfizer Investigational Site Amsterdam New York 12010 —
Pfizer Investigational Site Hudson New York 12534 —
Pfizer Investigational Site Latham New York 12110-0610 —
Pfizer Investigational Site Rexford New York 12148 —
Pfizer Investigational Site Troy New York 12180 —
Pfizer Investigational Site Kernersville North Carolina 27284 —
Pfizer Investigational Site Lexington North Carolina 27295 —
Pfizer Investigational Site Mount Airy North Carolina 27030 —
Pfizer Investigational Site North Wilkesboro North Carolina 28659 —
Pfizer Investigational Site Pollocksville North Carolina 28573 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Oregon City Oregon 97045 —
Pfizer Investigational Site Portland Oregon 97213 —
Pfizer Investigational Site Portland Oregon 97225 —
Pfizer Investigational Site Portland Oregon 97227 —
Pfizer Investigational Site Tualatin Oregon 97062 —
Pfizer Investigational Site West Reading Pennsylvania 19611 —
Pfizer Investigational Site Charleston South Carolina 29406 —
Pfizer Investigational Site Easley South Carolina 29640 —
Pfizer Investigational Site Greenville South Carolina 29605 —
Pfizer Investigational Site Greenville South Carolina 29615 —
Pfizer Investigational Site Seneca South Carolina 29672 —
Pfizer Investigational Site Spartanburg South Carolina 29307 —
Pfizer Investigational Site Chattanooga Tennessee 37403 —
Pfizer Investigational Site Franklin Tennessee 37067 —
Pfizer Investigational Site Gallatin Tennessee 37066 —
Pfizer Investigational Site Hermitage Tennessee 37076 —
Pfizer Investigational Site Lebanon Tennessee 37087 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site Nashville Tennessee 37205 —
Pfizer Investigational Site Nashville Tennessee 37207 —
Pfizer Investigational Site Nashville Tennessee 37211 —
Pfizer Investigational Site Smyrna Tennessee 37167 —
Pfizer Investigational Site Dallas Texas 75235 —
Pfizer Investigational Site Dallas Texas 75237 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site Dallas Texas 75390 —
Pfizer Investigational Site Fort Worth Texas 76177 —
Pfizer Investigational Site Houston Texas 77090 —
Pfizer Investigational Site Tyler Texas 75702 —
Pfizer Investigational Site Ogden Utah 84403-3274 —
Pfizer Investigational Site Everett Washington 98201 —
Pfizer Investigational Site Kennewick Washington 99336 —
Pfizer Investigational Site Vancouver Washington 98684 —
Pfizer Investigational Site Vancouver Washington 98686 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00460603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2013 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00460603 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →